Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
posted on
Dec 22, 2020 09:02AM
I agree that this is good news but also agree that it is meant to sooth the ire from the lack of success to come through with the much more important BoM2 partnership. It appears that another major promise will not come true.